Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

Greg Meyers, Executive Vice President and Chief Digital &amp; Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin shares how Boehringer Ingelheim&rsquo;s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin on the cutting edge of clinical trial design

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

Genentech’s John Marioni on enhancing drug discovery with data and AI

In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.

In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&amp;D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&amp;D, at Johnson &amp; Johnson Innovative Medicine (J&amp;J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.

J&J’s Ashita Batavia on advancing oncology clinical-trials with data

In this episode, hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and global head of AI and machine learning at GSK. They discuss how these emerging technologies are being used to potentially reshape how drugs are developed and about the complexities AI and machine learning introduce in data management, cross-functional collaboration, and responsible innovation.

In this episode,&nbsp;hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and global head of AI and machine learning at GSK. They discuss how these emerging technologies are being used to potentially reshape how drugs are developed and about the complexities AI and machine learning introduce in data management, cross-functional collaboration, and responsible innovation.

GSK's Kim Branson on driving innovation with AI and machine learning

In this episode, Howard Jacob, AbbVie’s vice president of genomics research and head of data integration, discusses early adoption of data integration at AbbVie, the challenges of medical silos, and the steps needed to build novel AI and machine learning capabilities with McKinsey’s Alex Devereson, Erika Stanzl, and Navraj Nagra. Together, explore how AI and genomics can better define diseases and discuss the importance of building trust in new technologies through patient-centric initiatives.

In this episode, Howard Jacob, AbbVie’s vice president of genomics research and head of data integration, discusses early adoption of data integration at AbbVie, the challenges of medical silos, and the steps needed to build novel AI and machine learning capabilities with McKinsey’s Alex Devereson, Erika Stanzl, and Navraj Nagra. Together, explore how AI and genomics can better define diseases and discuss the importance of building trust in new technologies through patient-centric initiatives.

AbbVie’s head of genomics research on the transformative power of AI

Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.

Learn more about the McKinsey R&D practice here.

Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.
Learn more about the McKinsey R&amp;D practice <a href="https://www.mckinsey.com/industries/life-sciences/how-we-help-clients">here</a>.

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma. 

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Eureka!

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Eureka!

Social links:

Follow the podcast:

7 clip(s)